Know Labs, Inc. (KNW)

NYSEAMERICAN: KNW · IEX Real-Time Price · USD
0.482
+0.012 (2.55%)
Feb 23, 2024, 4:00 PM EST - Market closed
2.55%
Market Cap 39.21M
Revenue (ttm) n/a
Net Income (ttm) -20.13M
Shares Out 81.35M
EPS (ttm) -0.37
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 210,657
Open 0.487
Previous Close 0.470
Day's Range 0.465 - 0.497
52-Week Range 0.230 - 1.480
Beta 1.67
Analysts n/a
Price Target n/a
Earnings Date Feb 14, 2024

About KNW

Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in ... [Read more]

Sector Technology
Founded 1998
Employees 12
Stock Exchange NYSEAMERICAN
Ticker Symbol KNW
Full Company Profile

Financial Performance

Financial Statements

News

Know Labs, Inc. Reports First Quarter FY2024 Results

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the first quarter ended Decemb...

11 days ago - Business Wire

Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...

18 days ago - Business Wire

Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the company will be exhibiting at the International...

4 weeks ago - Business Wire

Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and fiscal ...

2 months ago - Business Wire

Know Labs Expands Medical and Scientific Advisory Board

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of four new members to the Company'...

2 months ago - Business Wire

Know Labs, Inc. to Host Review of Fiscal Year 2023 Results on December 19, 2023

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...

2 months ago - Business Wire

Know Labs Expands Board of Directors

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of three new members to the Company...

3 months ago - Business Wire

Know Labs Presents at Third Annual Bernstein CGM Disruptors Conference, Details Significant Progress During the Past Year

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, will present at the third annual Bernstein CGM Disruptors Conferenc...

4 months ago - Business Wire

Know Labs, Inc. Announces Pricing of $7 Million Public Offering of Common Stock

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the “Company”), an emerging developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment un...

5 months ago - Business Wire

Know Labs, Inc. Reports Third Quarter FY2023 Results

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter ended June 3...

6 months ago - Business Wire

Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2023 Results on August 14, 2023

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...

7 months ago - Business Wire

Know Labs Demonstrates Improved Accuracy of Machine Learning Model for Non-Invasive Glucose Monitor

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) today announced results from a new study titled, “Novel data preprocessing techniques in an expanded dataset improve machine learning mod...

7 months ago - Business Wire

Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring

SEATTLE--(BUSINESS WIRE)--Know Labs (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, revealed the next stage in the development of its proprietary Bio-RFID™ t...

9 months ago - Business Wire

Know Labs' Non-Invasive Glucose Monitoring Technology Shows Improved Accuracy

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) today announced the results of a new study titled, “Algorithm Refinement in the Non-Invasive Detection of Blood Glucose Using Know Labs' ...

9 months ago - Business Wire

Know Labs, Inc. Discusses Significant Growth of Its IP Portfolio and 2023 Goals with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - May 25, 2023) - The Stock Day Podcast welcomed Know Labs, Inc. (NYSE American: KNW) ("the Company"), an emerging developer of non-invasive medical diagnostic techno...

9 months ago - Newsfile Corp

Know Labs Joins IPBC Global 2023 to Discuss the Importance of Strategic IP Development in Maximizing Shareholder Value

SEATTLE--(BUSINESS WIRE)--Know Labs (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced that Pete Conley, its Chief Financial Officer and Senior ...

9 months ago - Business Wire

Know Labs Furthers External Validation of Bio-RFID™ Technology with Study Published in Sensors Journal

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the publication of its first peer-reviewed study in...

10 months ago - Business Wire

Know Labs, Inc. Reports Second Quarter FY2023 Results

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter ended March...

10 months ago - Business Wire

Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2023 Results on May 15, 2023

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...

10 months ago - Business Wire

Know Labs Study Validates Technical Feasibility of its Novel Sensor for Non-Invasive Glucose Monitoring

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the results of its latest technical feasibility stu...

10 months ago - Business Wire

Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Proof-of-Principle Study

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the results of a proof-of-principle study titled, “...

11 months ago - Business Wire

Know Labs Forms New Scientific Advisory Board, Appoints Respected Researchers in Medical Innovation as First Members

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the establishment of a Scientific Advisory Board (S...

1 year ago - Business Wire

Know Labs, Inc. Reports First Quarter 2023 Results

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the first quarter ended Decemb...

1 year ago - Business Wire

Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2023 Results on February 14, 2023

Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2023 Results on February 14, 2023

1 year ago - Business Wire

Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today shared an update on its strategic partnerships with leading...

1 year ago - Business Wire